Determination of mitiglinide in rat plasma by high-performance liquid chromatography with UV detection
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-04-13
著者
-
Zeng Su
Department Of Pharmaceutical Analysis And Drug Metabolism College Of Pharmaceutical Sciences Zhejian
-
Zeng Su
Department Of Pharmaceutical Analysis And Drug Metabolism College Of Pharmaceutical Sciences Zhejian
-
Yu Lushan
Department Of Pharmaceutical Analysis And Drug Metabolism College Of Pharmaceutical Sciences Zhejian
-
Yu Lushan
Department Of Pharmaceutical Analysis And Drug Metabolism College Of Pharmaceutical Sciences Zhejian
関連論文
- Simultaneous determination of mandelic acid enantiomers and phenylglyoxylic acid in urine by high-performance liquid chromatography with precolumn derivatization
- Determination of rutin deca(H-) sulfate sodium in rat plasma using ion-pairing liquid chromatography ater ion-pairing solid-phase extraction
- Simultaneous determination of the enantiomers of esmolol and its acid metabolite in human plasma by reversed phase liquid chromatography with solid-phase extraction
- Ion-pair reverse-phase high performance liquid chromatography method for determination of Huperzine-A in beagle dog serum
- Development of high performance liquid chromatography/electrospray ionization mass spectrometry for assay of ginkgolic acid (15:1) in rat plasma and its application to pharmacokinetics study
- Identification and simultaneous determination of p-FHA and p-FBA, two metabolites of anti-tumor agent-Fluorapacin in rat urine
- Determination of anti-tumor agent bis(p-fluorobenzyl)trisulfide and its degraded compound in rat blood using reversed phase high-performance liquid chromatography
- Determination of mitiglinide in rat plasma by high-performance liquid chromatography with UV detection
- Enantiomeric separation of norgestrel by reversed phase high-performance liquid chromatography using eluents containing hydroxypropyl-beta-cyclodextrin in stereoselective skin permeation study
- Stereoselective Glucuronidation of Propafenone and Its Analogues by Human Recombinant UGT1A9